United States: 4 Life Science Innovations That Give Life To Patent Growth

Last Updated: July 7 2015
Article by Kevin M. Granahan

Co-authored by summer associate David Magagna

Originally published on Law360

For all of the optimism in recent years regarding worldwide innovation and advancements in technology across all industries, would it surprise you to learn that total global patent volume increased by a meager 3 percent in 2014? Or that this 3 percent growth rate represents the worst patent volume growth rate since 2009, one year removed from the worst global recession since the Great Depression-Stunted growth in patent volume in 2014 did not confine itself to one specific industry, as many traditional innovators, such as semiconductors, aerospace and defense, struggled to produce new patents. In fact, in 2014 semiconductors and aerospace and defense saw their patent volume plummet by 5 percent and 1 percent, respectively.

Innovation in the Life Sciences Industry

Not all of 2014's innovation and patent news disappointed, however, as the life sciences industry posted strong results. The pharmaceutical and biotech sectors of the industry in particular saw patent growth rate increases of 12 percent and 7 percent, respectively. This strong growth is due to a number of factors, including (1) a strong boost from substantial government spending in the life sciences industry in the U.S., (2) significant shifts in the manner in which governments are paying for medical products and services, (3) an aging worldwide population that continues to need health care and related medical treatments to address an increasing number of medical conditions and improve lifestyle and (4) the existence of an inelastic demand for products and services offered by companies operating within the life sciences industry. This article briefly examines each of these factors and presents the case that the innovation and patent growth seen in the life sciences industry in 2014 will not be slowing down any time in the near future.

1. Government Spending

The recent influx of both federal and state health care spending in the U.S. has had an immense impact on innovation in life sciences. The Affordable Care Act has substantially increased dollars devoted to health care as a result of the expansion of Medicaid coverage and the provision of financial incentives to states for establishing government-backed insurance exchanges. The ACA also implicitly drives additional private financial resources towards health care spending since it requires all U.S. citizens to carry some form of health insurance. This insurance mandate alone has dramatically expanded the life sciences industry's market as a result of a substantial majority of the 16.5 million previously uninsured Americans gaining coverage. These newly insured individuals will be much more likely to access health care and medical products and services offered by the life sciences industry. These additional financial resources have allowed such companies to maintain strong cash positions, thereby permitting them to explore and experiment with innovative new therapies and ultimately file new patents.

2. Shifts in Government Payment Methods

While cash certainly remains king, the manner in which that cash is expended by the government has also greatly impacted the life sciences industry. Under the ACA, the U.S. government no longer reimburses medical care providers based purely on volume or the amount of patients treated. Instead, the government has shifted its focus to the total value of the medical treatment with respect to the volume of patients treated. This value model is intended to allow both medical care providers and the government to evaluate the products and services offered by life sciences companies based on both quality and cost and inherently provides an incentive to these companies to develop high-quality products and services in the most efficient and cost-effective manner possible. Life sciences companies are therefore in a prime position to take advantage of this paradigm shift and to pave the way for the new age value-based medical marketplace envisioned by our medical care providers and government alike. Innovation and patent growth are logical outcomes and will surely continue to follow.

3. Aging Populations

As is likely the case with successful companies operating in most other industries, life sciences companies have seen the writing on the wall for some time. For years, these companies have studied demographic trends and are keenly aware of the impact that an aging worldwide population will have on general economic conditions, health care developments and the medical marketplace in particular. In the U.S., the largest demographic population, the so-called"baby boomers,"are retired or approaching retirement age, causing dramatic changes in the health care field. As these baby boomers age and increasingly encounter problems that are traditionally associated with old age and challenge their lifestyle, such as Alzheimer's disease, diabetes, arthritis, hypertension and other chronic medical conditions, their demand for quality health care and innovative medical products and services will also continue to increase. This rising demand present in aging populations throughout the world is therefore one of the key factors driving revenue growth and expanding market opportunity among successful life sciences companies.

4. Inelastic Demand for Products and Services

While the aging worldwide population is a market development that most other industries have seen for some time, the life sciences industry is in a unique position when compared with other industries because it enjoys the benefit of a generally inelastic demand for its products and services. Most consumers purchase medical products and services out of necessity and not as a result of a personal desire or want. Since health care and medical treatments are often a necessity, many of these purchases are made regardless of price. For example, most diabetics consider their insulin injections to be a necessity and treat the expense associated with these injections as a fixed cost that is simply part of their lives. This relatively stable market position allows financial analysts to more accurately predict and forecast future revenue streams for life sciences companies, thereby allowing the companies to attract further capital and invest in innovation and patents, even in tough economic times.

Of course, not all industries are as fortunate. For example, consider the automotive industry and the mistakes several well-known U.S. automobile manufacturers made prior to the financial crash of 2008. These companies built automotive brands based on bulk and not on practical consumer needs, generally focusing on large trucks and sport utility vehicles. When gas prices later spiked dramatically, sales for these companies plummeted, most notably with respect to these large, gas-guzzling vehicles. Successful companies in the life sciences industry, on the other hand, have focused and continue to focus on consumer needs and have therefore positioned themselves to be less sensitive to general macroeconomic pressures that often affect other industries.


With a rapidly increasing and largely inelastic demand resulting from health-conscious and aging populations located throughout the world (many of which typically have access to an ever-increasing amount of medical research and information) and the relative availability of capital, the life sciences industry is in an enviable position, especially when compared with other industries competing for revenues. It is therefore no surprise that the sector has seen patent growth that has outpaced many other industries and there is no reason to believe that this growth will not continue in the future. For all of the aforementioned reasons, there can only be one word used to describe the life sciences industry's outlook: healthy.

Originally published by Law360

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Kevin M. Granahan
Similar Articles
Relevancy Powered by MondaqAI
Fox Rothschild LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Fox Rothschild LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions